EX9 Analysis

Exelixis, Inc.
Stock Exchange: XETRA
Sector: biotechnology
19.17
Last session price
19.17
Price now
Currency: EUR
Reporting currency: USD
ISIN: US30161Q1040
INN:
.

EX9 financial statements

* Numbers in millions
Capitalization * 5 801
EV * 5 365
Number of shares * 303
EPS 0,37
Revenue * 988
Net income * 112
Operating profit * 110
Total liabilities * 258
Net debt * -270
Total assets * 2 137
Equity * 1 879
Cash and investments * 1 207
.

EX9 valuation

P/E 51,89
P/B 3,09
P/S 5,87
E/P 2
P/FCF 32,47
.

EX9 profitability

ROE 6%
ROA% 5%
ROIC% 6%